TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC
Abstract TOPK/PBK (T-LAK Cell-Originated Protein Kinase) is a serine/threonine kinase that is highly expressed in a variety of human tumors and is associated with poor prognosis in many types of human malignancies. Its activation mechanism is not yet fully understood. A bidirectional signal transduc...
Main Authors: | Huimin Sun, Jianzhong Zheng, Juanjuan Xiao, Juntao Yue, Zhiyuan Shi, Zuodong Xuan, Chen Chen, Yue Zhao, Wenbin Tang, Shaopei Ye, Jinxin Li, Qiumin Deng, Lei Zhang, Feng Zhu, Chen Shao |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-05-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-022-04909-3 |
Similar Items
-
PBK/TOPK: A Therapeutic Target Worthy of Attention
by: Ziping Han, et al.
Published: (2021-02-01) -
PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential
by: Hai Huang, et al.
Published: (2021-05-01) -
TOPK mediates immune evasion of renal cell carcinoma via upregulating the expression of PD-L1
by: Jinxin Li, et al.
Published: (2023-07-01) -
Overexpression of PBK/TOPK relates to poor prognosis of patients with breast cancer: a retrospective analysis
by: Liang Qiao, et al.
Published: (2022-09-01) -
PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers
by: Dong-Hee Lee, et al.
Published: (2022-01-01)